Diabetes News Chronicle


Diabetes, Cardiovascular And Heart Diseases - 219

 

Published on July 30, 2017 at 01:00 PM GMT

REMOVAL trial shows heart disease risk reduction with metformin medication

REMOVAL trial shows heart disease risk reduction with metformin medication A study done by researchers at the University of Glasgow, Scotland shows long-term risk reduction to heart disease with metformin diabetes medication in middle aged type 1 diabetes (T1D) patients who are with increased cardiovascular diseases (CVD) risk factors. In the REMOVAL trial, researchers used ultrasound to measure atherosclerosis of the carotid arteries in the neck area, which supply blood to neck, face and brain. Total number of adult participants in the REMOVAL trial were 428 with more than 40 years of age and having long standing type 1 diabetes (T1D) complication. The participants in the trial had at least three of the following cardiovascular diseases (CVD) risk factors.

During the 3 years duration REMOVAL trial period, the participants were under either metformin or matching placebo medication. Researchers observed following in the participants during the trial.

Researchers attributed reduction in the atherosclerosis to metformin drug treatment, which reduced body weight and cholesterol levels. Researchers says their REMOVAL trial shows heart disease risk reduction to type 1 diabetes (T1D) patients with the metformin medication. They also says guidelines should be updated as their study shows metformin drug reduces blood sugar or glucose levels for a very short period of time. The chief investigator of the study was Professor John Petrie, MD, PhD, at the University of Glasgow, Scotland. The study findings were presented to the American Diabetes Association during 77th Scientific Sessions, San Diego Convention Center, United States. The study findings were published June 11, 2017 in The Lancet Diabetes & Endocrinology. Title of the article was "Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial".

Articles related to   Heart Diseases   |   Health Risks   |   Metformin

 

Pre-eclampsia or gestational hypertension was linked to increased future heart disease risk in women

Pre-eclampsia or gestational hypertension was linked to increased future heart disease risk in women The Heart Foundation, Australia says there is an enhanced risk to future heart diseases in those women who suffered pre-eclampsia or gestational hypertension during pregnancy. Ms Julie Anne Mitchell, national spokeswoman on women's heart health of The Heart Foundation, Australia says those women should monitor their heart health after pregnancy. They call pregnancy as an "ultimate cardiac stress test". In Australia, studies shows during pregnancy, around 30,000 women develop high blood pressure and 10,000 of them with pre-eclampsia condition. This dangerous complication force heart to work harder. Earlier studies shows following enhanced future complications with pre-eclampsia or gestational hypertension.

Articles related to   Gestational   |   Hypertension   |   Heart Diseases   |   Health Risks   |   Women

 

 

Categories

Sitemap 1

Sitemap 2

Sitemap 3

Articles related to Acids Page 1  

Articles related to Approval Page 1  

Articles related to Apps Page 1   Page 2  

Articles related to Blood Sugar Levels Page 1  

Articles related to Blood-pressure Page 1  

Articles related to Cancer Page 1  

Articles related to Cardiovascular Diseases Page 1  

Articles related to Children Page 1  

Articles related to Cholesterol Page 1  

Articles related to Dementia Page 1  

Articles related to Dental Problems Page 1  

Articles related to Depression Page 1  

Articles related to Drugs Page 1   Page 2  

Articles related to Eldercare Page 1  

Articles related to Gut Microbiomes Page 1  

Articles related to Health Benefits Page 1   Page 2  

Articles related to Health Biomarkers Page 1  

Articles related to Health Risks Page 1   Page 2   Page 3   Page 4   Page 5  

Articles related to Health Supplements Page 1   Page 2  

Articles related to Heart Diseases Page 1   Page 2   Page 3  

Articles related to Hormones Page 1  

Articles related to Insulin Page 1   Page 2  

Articles related to Kidney Page 1  

Articles related to Liver Diseases Page 1  

Articles related to Metformin Page 1  

Articles related to Miscellaneous Page 1  

Articles related to Neuropathy Page 1  

Articles related to Obesity Page 1  

Articles related to Physical Activity Page 1  

Articles related to Pollution Page 1  

Articles related to Precautions Page 1  

Articles related to Retinopathy Page 1  

Articles related to Sleeping Disorders Page 1  

Articles related to Stroke Page 1  

Articles related to Therapy Page 1  

Articles related to Weight Loss Surgery Page 1  

Articles related to Women Health Page 1   Page 2  

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.